Clinical Evidence: How Wegovy Compares To Mounjaro 7.5mg
Weight Loss Results: Wegovy Equivalent To Mounjaro 7.5 Clinical Evidence
When comparing Wegovy equivalent to Mounjaro 7.5mg weight loss results, it's essential to examine the clinical trial evidence for each medication separately. The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with some studies showing sustained results over 2 years. However, we cannot directly compare these results to Mounjaro trials due to different study designs, patient populations, and endpoints used in the research.
What makes this comparison particularly relevant for UK patients is understanding that both medications work through appetite regulation, though via different pathways. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, while Mounjaro's tirzepatide targets both GIP and GLP-1 receptors as a dual agonist. Both are prescription-only medicines requiring clinical assessment and ongoing medical supervision throughout treatment.
Pricing Comparison: Wegovy Equivalent To Mounjaro 7.5 Costs At EverydayMeds
Understanding the cost implications when considering Wegovy equivalent to Mounjaro 7.5mg is crucial for UK patients planning long-term weight management. At EverydayMeds, Wegovy pricing starts from £79.99 for the 0.25mg starter dose with our FIRST40 discount code for new customers, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenient supply continuity, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99, ensuring uninterrupted treatment during dose escalation.
For returning customers, our DOSE25 discount code applies at checkout, and all orders include temperature-controlled next-day delivery once approved by our prescribing team. Both Wegovy and Mounjaro require identical clinical assessment processes through our GPhC-registered pharmacy (#9012878), with standard prescriber review taking 3 working days or express 24-hour options available for urgent requirements.
STEP Trial Results: Wegovy Equivalent To Mounjaro 7.5 Evidence Base
The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness in weight management when used alongside lifestyle interventions. STEP 1 demonstrated approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, while STEP 3 achieved around clinically studied weight loss when combined with intensive behavioural therapy. The long-term STEP 5 study showed sustained weight loss of approximately 15.2% at 2 years, as published by Wilding et al. in the New England Journal of Medicine, 2021.
Additionally, the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events, highlighting potential benefits beyond weight management. These results represent clinical trial conditions with carefully selected participants following structured diet and exercise programmes, and individual results may vary significantly based on adherence, lifestyle factors, and underlying health conditions.
Mechanism Differences: How Wegovy Equivalent To Mounjaro 7.5 Works
Understanding how Wegovy works compared to Mounjaro 7.5mg helps explain their different approaches to weight management. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a natural hormone released after eating that signals fullness to the brain. This mechanism may help reduce appetite, promote earlier satiety after meals, and potentially decrease food cravings by acting on appetite centres in the brain. The once-weekly injection using the FlexTouch pen device provides consistent medication levels, supporting sustained appetite regulation throughout the week. Clinical studies suggest this mechanism may help patients feel satisfied with smaller portions and experience reduced urges to eat between meals, though individual responses can vary considerably.
Ordering Process: Getting Wegovy Equivalent To Mounjaro 7.5 Through EverydayMeds
Accessing Wegovy equivalent to Mounjaro 7.5mg comparison through EverydayMeds begins with our streamlined 3-minute online clinical assessment, designed to gather essential medical history and current health information required for prescriber review. Our qualified prescribers evaluate each application against MHRA licensing criteria, considering factors such as BMI requirements, existing medical conditions, current medications, and previous weight management attempts. Standard prescriber review takes 3 working days, though express 24-hour review is available for urgent requirements, with all assessments conducted by UK-registered healthcare professionals. Once approved, orders are dispatched via temperature-controlled next-day delivery, maintaining the cold-chain integrity essential for maintaining medication stability and efficacy. Our customer support team remains available throughout the process to address questions about dosing, injection technique, or treatment expectations.
Storage Advantages: Wegovy Equivalent To Mounjaro 7.5 Practical Considerations
Storage requirements present a practical advantage when comparing Wegovy equivalent to Mounjaro 7.5mg for UK patients with active lifestyles. Wegovy maintains stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for extended travel or situations where refrigeration access is limited. The FlexTouch pen delivery system provides precise dosing with clear visual confirmation of injection completion, while the mandatory dose escalation schedule (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) helps minimise gastrointestinal side effects during treatment initiation. Patients must store unused pens in the refrigerator at 2-8°C and should never freeze the medication, as this permanently damages the active ingredient. The pen should be kept in its original carton to protect from light, and patients should inspect the solution before each injection to ensure it remains clear and colourless.
UK-Specific Considerations: Wegovy Equivalent To Mounjaro 7.5 NICE Guidance
NICE guidance TA875 specifically recommends Wegovy for eligible adults when used alongside specialist weight management support, providing NHS framework validation for this treatment approach. UK patients considering Wegovy equivalent to Mounjaro 7.5mg should understand that both medications are subject to MHRA additional monitoring, indicated by the Black Triangle (▼) symbol, meaning healthcare professionals are encouraged to report any suspected adverse reactions. This enhanced monitoring reflects their relatively recent introduction to the UK market rather than specific safety concerns.
The MHRA licensing covers adults with BMI ≥30 kg/m², or BMI ≥27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or sleep apnoea. Both treatments must be prescribed alongside a reduced-calorie diet and increased physical activity, emphasising the importance of comprehensive lifestyle modification rather than medication alone for optimal weight management outcomes.
Making Your Choice: Wegovy Equivalent To Mounjaro 7.5 Next Steps
Ready to explore whether Wegovy equivalent to Mounjaro 7.5mg comparison suits your weight management goals? EverydayMeds offers both treatments through our comprehensive prescriber assessment process, with new customers using discount code FIRST40 and returning patients applying DOSE25 at checkout. Our clinical team can help evaluate which option aligns with your medical history, lifestyle requirements, and treatment preferences during the assessment process. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, with express prescriber review available for urgent requirements. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment approach best supports your individual weight management journey. Our GPhC-registered pharmacy (#9012878) ensures professional oversight throughout your treatment, from initial assessment through ongoing supply and clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
